|
1
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sanz-Moreno V, Gadea G, Ahn J, Paterson H,
Marra P, Pinner S, Sahai E and Marshall CJ: Rac activation and
inactivation control plasticity of tumor cell movement. Cell.
135:510–523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rao SS, Bentil S, DeJesus J, Larison J,
Hissong A, Dupaix R, Sarkar A and Winter JO: Inherent interfacial
mechanical gradients in 3D hydrogels influence tumor cell
behaviors. PloS One. 7:e358522012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parri M and Chiarugi P: Rac and Rho
GTPases in cancer cell motility control. Cell Commun Signal.
8:232010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiglaire Jiguet C, Baeza-Kallee N,
Denicolaï E, Barets D, Metellus P, Padovani L, Chinot O,
Figarella-Branger D and Fernandez C: Ex vivo cultures of
glioblastoma in three-dimensional hydrogel maintain the original
tumor growth behavior and are suitable for preclinical drug and
radiation sensitivity screening. Exp Cell Res. 321:99–108. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zengel P, Nguyen-Hoang A, Schildhammer C,
Zantl R, Kahl V and Horn E: µ-Slide chemotaxis: A new chamber for
long-term chemotaxis studies. BMC Cell Biol. 12:212011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gouwy M, De Buck M, Pörtner N, Opdenakker
G, Proost P, Struyf S and Van Damme J: Serum amyloid A
chemoattracts immature dendritic cells and indirectly provokes
monocyte chemotaxis by induction of cooperating CC and CXC
chemokines. Eur J Immunol. 45:101–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thiele J, Ma Y, Bruekers SM, Ma S and Huck
WT: 25th anniversary article: Designer hydrogels for cell cultures:
A materials selection guide. Adv Mater. 26:125–147. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu KV, Chang JP, Parachoniak CA, Pandika
MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ,
Cheresh DA, et al: VEGF inhibits tumor cell invasion and
mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell.
22:21–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9:1942010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Symons M and Segall JE: Rac and Rho
driving tumor invasion: Who's at the wheel? Genome Biol.
10:2132009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamazaki D, Kurisu S and Takenawa T:
Involvement of Rac and Rho signaling in cancer cell motility in 3D
substrates. Oncogene. 28:1570–1583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhong J, Paul A, Kellie SJ and O'Neill GM:
Mesenchymal migration as a therapeutic target in glioblastoma. J
Oncol. 2010:4301422010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wuichet K and Søgaard-Andersen L:
Evolution and diversity of the Ras superfamily of small GTPases in
prokaryotes. Genome Biol Evol. 7:57–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haga RB and Ridley AJ: Rho GTPases:
Regulation and roles in cancer cell biology. Small GTPases.
7:207–221. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murali A and Rajalingam K: Small Rho
GTPases in the control of cell shape and mobility. Cell Mol Life
Sci. 71:1703–1721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rape AD and Kumar S: A composite hydrogel
platform for the dissection of tumor cell migration at tissue
interfaces. Biomaterials. 35:8846–8853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ren B, Yu S, Chen C, Wang L, Liu Z, Wu Q,
Wang L, Zhao K and Yang X: Invasion and anti-invasion research of
glioma cells in an improved model of organotypic brain slice
culture. Tumori. 101:390–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Flemming A: Cancer: Multifunctional
nanodevice reverses drug resistance. Nat Rev Drug Discov.
14:3092015. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shea LD, Woodruff TK and Shikanov A:
Bioengineering the ovarian follicle microenvironment. Annu Rev
Biomed Eng. 16:29–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Souza GR, Molina JR, Raphael RM, Ozawa MG,
Stark DJ, Levin CS, Bronk LF, Ananta JS, Mandelin J, Georgescu MM,
et al: Three-dimensional tissue culture based on magnetic cell
levitation. Nat Nanotechnol. 5:291–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reymond N, Im JH, Garg R, Vega FM, d'Agua
Borda B, Riou P, Cox S, Valderrama F, Muschel RJ and Ridley AJ:
Cdc42 promotes transendothelial migration of cancer cells through
β1 integrin. J Cell Biol. 199:653–668. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Navarro-Lérida I, Pellinen T, Sanchez SA,
Guadamillas MC, Wang Y, Mirtti T, Calvo E and Del Pozo MA: Rac1
nucleocytoplasmic shuttling drives nuclear shape changes and tumor
invasion. Dev Cell. 32:318–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sadok A, McCarthy A, Caldwell J, Collins
I, Garrett MD, Yeo M, Hooper S, Sahai E, Kuemper S, Mardakheh FK
and Marshall CJ: Rho kinase inhibitors block melanoma cell
migration and inhibit metastasis. Cancer Res. 75:2272–2284. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mishima T, Naotsuka M, Horita Y, Sato M,
Ohashi K and Mizuno K: LIM-kinase is critical for the
mesenchymal-to-amoeboid cell morphological transition in 3D
matrices: Biochem Biophys Res Commun. 392:577–581. 2010.
|
|
27
|
Panková K, Rösel D, Novotný M and Brábek
J: The molecular mechanisms of transition between mesenchymal and
amoeboid invasiveness in tumor cells. Cell Mol Life Sci. 67:63–71.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Desgrosellier JS, Barnes LA, Shields DJ,
Huang M, Lau SK, Prévost N, Tarin D, Shattil SJ and Cheresh DA: An
integrin alpha(v)beta(3)-c-Src oncogenic unit promotes
anchorage-independence and tumor progression. Nat Med.
15:1163–1169. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seguin L, Kato S, Franovic A, Camargo MF,
Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, et
al: An integrin β3-KRAS-RalB complex drives tumour
stemness and resistance to EGFR inhibition. Nat Cell Biol.
16:457–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
